MiR‐148‐3p is significantly reduced in glioma tissues compared to adjacent nontumor tissues and correlated with various factors, including WHO grade, tumour size, prognosis, as well as DNMT1 and RUNX3 expressions. This evidence concerns the gene DNMT1 and central nervous system cancer.